BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 20694007)

  • 1. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein.
    Hirschi A; Cecchini M; Steinhardt RC; Schamber MR; Dick FA; Rubin SM
    Nat Struct Mol Biol; 2010 Sep; 17(9):1051-7. PubMed ID: 20694007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the antagonism of retinoblastoma protein dephosphorylation by PNUTS provides insights into the PP1 regulatory code.
    Choy MS; Hieke M; Kumar GS; Lewis GR; Gonzalez-DeWhitt KR; Kessler RP; Stein BJ; Hessenberger M; Nairn AC; Peti W; Page R
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4097-102. PubMed ID: 24591642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix.
    Topacio BR; Zatulovskiy E; Cristea S; Xie S; Tambo CS; Rubin SM; Sage J; Kõivomägi M; Skotheim JM
    Mol Cell; 2019 May; 74(4):758-770.e4. PubMed ID: 30982746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.
    Wallace M; Ball KL
    Mol Cell Biol; 2004 Jun; 24(12):5606-19. PubMed ID: 15169919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.
    Iwahori S; Hakki M; Chou S; Kalejta RF
    J Biol Chem; 2015 Aug; 290(32):19666-80. PubMed ID: 26100623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control.
    Burke JR; Hura GL; Rubin SM
    Genes Dev; 2012 Jun; 26(11):1156-66. PubMed ID: 22569856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase.
    Meng F; Qian J; Yue H; Li X; Xue K
    Cell Cycle; 2016 Jul; 15(13):1724-32. PubMed ID: 27163259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PP1 and PP2A phosphatases--cooperating partners in modulating retinoblastoma protein activation.
    Kolupaeva V; Janssens V
    FEBS J; 2013 Jan; 280(2):627-43. PubMed ID: 22299668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
    Pan W; Cox S; Hoess RH; Grafström RH
    Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleocytoplasmic shuttling of the retinoblastoma tumor suppressor protein via Cdk phosphorylation-dependent nuclear export.
    Jiao W; Datta J; Lin HM; Dundr M; Rane SG
    J Biol Chem; 2006 Dec; 281(49):38098-108. PubMed ID: 17043357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
    Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
    Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM; Gall AL; Zheng N; Pavletich NP
    Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture.
    Hassler M; Singh S; Yue WW; Luczynski M; Lakbir R; Sanchez-Sanchez F; Bader T; Pearl LH; Mittnacht S
    Mol Cell; 2007 Nov; 28(3):371-85. PubMed ID: 17996702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Strategy for Direct Chemical Activation of the Retinoblastoma Protein.
    Pye CR; Bray WM; Brown ER; Burke JR; Lokey RS; Rubin SM
    ACS Chem Biol; 2016 May; 11(5):1192-7. PubMed ID: 26845289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.
    Ewen ME; Sluss HK; Sherr CJ; Matsushime H; Kato J; Livingston DM
    Cell; 1993 May; 73(3):487-97. PubMed ID: 8343202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the homolog of the oncoprotein gankyrin, an interactor of Rb and CDK4/6.
    Padmanabhan B; Adachi N; Kataoka K; Horikoshi M
    J Biol Chem; 2004 Jan; 279(2):1546-52. PubMed ID: 14583612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis.
    Delston RB; Matatall KA; Sun Y; Onken MD; Harbour JW
    Oncogene; 2011 Feb; 30(5):588-99. PubMed ID: 20871633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
    Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
    Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells.
    Gubern A; Joaquin M; Marquès M; Maseres P; Garcia-Garcia J; Amat R; González-Nuñez D; Oliva B; Real FX; de Nadal E; Posas F
    Mol Cell; 2016 Oct; 64(1):25-36. PubMed ID: 27642049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F.
    Gorges LL; Lents NH; Baldassare JJ
    Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1151-60. PubMed ID: 18768921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.